Found 8 matching trials
Safety and Immunogenicity of RH5.1/Matrix-M in Adults and Infants Living in Tanzania PHASE1 This is an age de-escalation, dose-escalation open label randomised trial s...
Show More Location
Ifakara Health Institute Clinical Trial Facility
Learn More & Join Trial
A Study to Compare Two Dosing Regimens for a New Malaria Vaccine PHASE1 Malaria is a major public health problem. There were around 240 million cas...
Show More Status
Active Not Recruiting
Location
Sheffield Teaching Hospitals, Royal Hallamshire Hospital
Learn More & Join Trial
A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine) PHASE1 This is a Phase Ib age de-escalation, dose escalation, open-label study to ...
Show More Location
Institut de Recherche en Sciences de la Santé
Learn More & Join Trial
A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines PHASE1 Malaria is a major public health problem. There were around 240 million cas...
Show More Location
Centre for Clinical Vaccinology & Tropical Medicine (CCVTM)
Learn More & Join Trial
A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso. PHASE1 This is a Phase IIb randomised controlled trial of the safety, immunogenici...
Show More Location
Institut de Recherche en Sciences de la Santé
Learn More & Join Trial
A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate PHASE1 This is an open-label, multi-centre Phase I/IIa dose escalation blood-stage...
Show More Location
Guys and St Thomas' NIHR CRF
Learn More & Join Trial
A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of the Blood-stage Malaria Candidate Vaccines RH5.1 in Matrix-M and R78C in Matrix-M in Healthy UK Adults EARLY_PHASE1 This is an open-label, single-centre Phase I P. falciparum blood-stage vacc...
Show More Status
Active Not Recruiting
Location
CCVTM, University of Oxford, Churchill Hospital
Learn More & Join Trial
A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M PHASE2 This is a Phase IIb randomised controlled trial of the safety, immunogenici...
Show More Status
Active Not Recruiting
Location
Institut de Recherche en Sciences de la Sante - Clinical Research Unit of Nanoro (IRSS-URCN)
Learn More & Join Trial